Fulgent Genetics, Inc.
FLGTDiagnostics & Research
$21.68+0.74%As of Oct 29vs prior close
- Market cap
- $596.5M
- From 52W high
- −29.72%
- Revenue (LTM)
- $323.9M
- Net margin
- -26.05%
Nomior Score
29
Emerging BreakoutSpeculativeBottom 14% of the scored universe
Growth47
Quality30
Value37
Momentum43
Resilience36
Growth
+37.58%revenue a year over 9 fiscal years
YE16 $18.3MLTM $323.9M
Connections
Revenue to profitQ2 YE26
The operating loss was 42% of revenue, wider by 18 pts on a year.
Who owns it
2funds